HOME >> BIOLOGY >> NEWS
Mitokor publishes human mitochondrial genome sequencing study - American Journal of Human Genetics

San Diego, CA. (April 9, 2002) MitoKor today announced the publication of a large, wide ranging study analyzing the mitochondrial DNA sequences of more than 500 individuals of different ethnic origins in The American Journal of Human Genetics. The study succeeded in identifying novel patterns arising from geographically distinct subpopulations, and will form the basis of ongoing investigations aimed at uncovering the association of variations in mitochondrial DNA with diseases of aging such as Alzheimers and type 2 diabetes mellitus. The data may be accessed at http://www.mitokor.com/science/560mtdnas.php.

The paper entitled: Reduced-median-network analysis of complete mitochondrial DNA coding region sequences for the major African, Asian, and European haplogroups, outlines a large DNA sequencing study undertaken at MitoKor in collaboration with scientists from the University of Newcastle upon Tyne, England, the VA Medical Center and University of California, San Diego, and Massachusetts General Hospital, Harvard Medical School. The study analyzed mitochondrial DNA sequence variations between ethnically diverse populations providing important information concerning human molecular evolution and population genetics. This data will also form the basis from which to understand how changes in mitochondrial DNA sequence can affect susceptibility to disease.

Mitochondrial genetics is improving our understanding of human evolution and prehistoric migratory patterns. In addition, mitochondrial sequence variation has been implicated as a causative or contributing factor in a number of human diseases, commented Neil Howell, Ph.D Vice President of Research at MitoKor and the senior author of the paper. We are now combining these two aspects to understand the genetics of these complex disorders. This continuing study requires comparative sequence analysis of mitochondrial DNA from large, clinically-cha
'"/>

Contact: Ruey-Li Hwang
r.hwang@noonanrusso.com
415-677-4455 x209
Noonan/Russo Communications
9-Apr-2002


Page: 1 2

Related biology news :

1. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
2. Warren Pharmaceuticals publishes results of preclinical evaluation
3. Professor publishes book on historic mosquito wars
4. AGI publishes 42nd edition of Directory of Geoscience Departments
5. International HapMap Consortium publishes scientific strategy
6. Ingenium publishes biological characterization of first mouse model for kidney stones
7. OHSU researcher publishes first measurements of free-base nicotine in cigarette smoke
8. AGI publishes 41st edition of Directory of Geoscience Departments
9. Ingenium publishes groundbreaking research on genetic basis for motor neuron degeneration
10. USDA Forest Service publishes wildland-urban interface assessment
11. Cellzome publishes novel approach for the systematic use of protein interaction maps in drug discovery in Nature

Post Your Comments:
(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than ... of intellectual property at PNNL,s annual Intellectual Property ... The Department of Energy national laboratory named materials ... his work developing battery materials that can store ... electrical grid, and reduce the time it takes ...
(Date:5/23/2013)... 284 million tons of cargo, transit the Panama Canal each ... the Panama Canal Authority. Each time a ship passes through, ... Gatun Lake, which is also a source of water for ... However, the advent of very large "super" cargo ships, now ... demanded change. The Panama Canal is being expanded to create ...
(Date:5/23/2013)... Health at Emory University, along with partners at ... $4 million grant over four years to establish ... Exposome Research Center: Understanding Lifetime Exposures). The grant ... the United States. , The HERCULES Center ... Health Sciences (NIEHS) of the National Institutes of ...
Breaking Biology News(10 mins):PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... 2013 Graphite Metallizing Corporation announces ... mounted in stainless steel pillow blocks. This series ... with the application and installation versatility of pillow ... work exceptionally well when submerged in water, ... such as acids, alkalies, hydrocarbons, black liquor, and ...
(Date:5/23/2013)... The maker community is a contemporary group ... focus on learning practical skills while applying them creatively ... their ideas to life via crowdfunding. A subgroup within ... projects using biology. Glowing Plant has worked for months ... glow with bioluminescence genes, and has now pursued crowdfunding ...
(Date:5/23/2013)... Virobay, Inc. today announced that their development ... important milestone, as Virobay has now initiated a Phase ... S inhibitor.   The first Phase 1 ... designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics ... "The initiation of this Phase 1 trial with ...
(Date:5/23/2013)... 23, 2013 Northwest Biotherapeutics (NASDAQ: ... ® personalized immune therapies for solid tumor cancers, ... this year,s American Society Of Clinical Oncology (ASCO) meeting ... leadership role in immune therapy.  (Logo: ... is the pre-eminent conference focused on clinical treatment of ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: